Morgan Stanley (MS-PO) Research & Development (2009 - 2026)

Morgan Stanley has disclosed Research & Development across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• In Q1 2026, Research & Development rose 9.33% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.5 billion (up 8.51% YoY), while the FY2025 annual figure was $4.4 billion, up 8.07% from the prior year.
• Research & Development retreated to $1.1 billion in Q1 2026, from $1.2 billion in the prior quarter.
• Over the last five years, Research & Development for MS-PO reached as high as $1.2 billion in Q4 2025 and fell as low as $829.0 million in Q1 2022.
• The 5-year median for Research & Development is $987.0 million (2023), against an average of $995.4 million.
• Annual changes were most pronounced in 2022 — Research & Development rose 13.1% — and 2023, when it increased 5.79%.
• A 5-year view of Research & Development shows it stood at $933.0 million in 2022, then rose by 5.79% to $987.0 million in 2023, then gained by 7.29% to $1.1 billion in 2024, then advanced by 9.54% to $1.2 billion in 2025, then retreated by 1.03% to $1.1 billion in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $1.1 billion, $1.2 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.